Back to all events
Datum
16 June 2026 11:00–12:00
Price
€ 0.00
for non-members
€ 0.00
for members
Organized by
Scilife
Event type News labels / tags
Other
Software & IT

Inspection-ready by design: scaling GxP quality systems for DACH life sciences

Inspection-ready by design: scaling GxP quality systems for DACH life sciences

🧩 Scaling your biotech company with disconnected quality systems?
That’s a compliance headache waiting to happen.

Join our free webinar to learn how DACH biotech companies can streamline #GxP quality processes, stay inspection-ready, and scale with a connected eQMS approach.

Many DACH biotech and life sciences companies focus heavily on clinical development early on, only to face operational and compliance challenges as they scale across GCP, GMP, and QA activities. Disconnected systems, fragmented documentation, and manual processes can quickly create complexity. 

In this session, Anke Ackermann (neé Zampich), GxP Strategy Advisor, Owner of QA-System, Santosh Paragond, Account Executive, and Angel Buendía, Knowledge Manager, will discuss how growing companies can build a connected, inspection-ready quality ecosystem from the start.

We’ll cover how to:
• Avoid common pitfalls when transitioning from clinical to broader GxP operations.
• Reduce risks caused by fragmented documentation and disconnected quality processes.
• Build scalable quality management processes across GCP and GMP activities.
• Meet regulatory expectations for traceability, version control, and process oversight.
• Centralize and scale quality processes through a unified eQMS approach.

The session will conclude with a live demonstration of how Scilife helps biotech and life sciences companies streamline and scale quality management in one connected platform.

📅 June 16th, 2026 | 11:00H (CEST)

Register for free now

Straight to the point, practical, and built for growing life sciences companies looking to scale quality with confidence.

Upcoming events

-
Medical Device Seminar Series 2026 – The EU Medical Device Regulation in Motion: Regulators, Industry and the Road Ahead